These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12564334)

  • 1. The ART of rationing--the need for a new approach to rationing health interventions.
    Kenyon C; Skordis J; Boulle A; Pillay K
    S Afr Med J; 2003 Jan; 93(1):56-60. PubMed ID: 12564334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
    Boulle A; Kenyon C; Skordis J; Wood R
    S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the 'cost-effectiveness' algorithm.
    Moatti JP; Marlink R; Luchini S; Kazatchkine M
    AIDS; 2008 Jul; 22 Suppl 1():S59-66. PubMed ID: 18664955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to rationing antiretroviral treatment: ethical and equity implications.
    Bennett S; Chanfreau C
    Bull World Health Organ; 2005 Jul; 83(7):541-7. PubMed ID: 16175829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting.
    Cleary S; Mooney G; McIntyre D
    Health Econ; 2010 Oct; 19(10):1166-80. PubMed ID: 19725025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.
    Sauvageot D; Schaefer M; Olson D; Pujades-Rodriguez M; O'Brien DP
    Pediatrics; 2010 May; 125(5):e1039-47. PubMed ID: 20385636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy (ART) rationing and access mechanisms and their impact on youth ART utilization in Malawi.
    Dixon JG; Gibson S; McPake B; Maleta K
    Malawi Med J; 2011 Jun; 23(2):48-54. PubMed ID: 23074812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scale-ups, scarcity, and selections: the experience of doctors in South Africa.
    Bayer R; Oppenheimer GM
    AIDS; 2007 Oct; 21 Suppl 5():S43-7. PubMed ID: 18090267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
    Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):283-93. PubMed ID: 22525829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationing access to public-sector antiretroviral treatment during scale-up in South Africa: implications for equity.
    Jacobs N; Schneider H; Van Rensburg HC
    Afr J AIDS Res; 2008 May; 7(1):19-27. PubMed ID: 25871268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is antiretroviral therapy cost-effective in South Africa?
    Braithwaite RS; Tsevat J
    PLoS Med; 2006 Jan; 3(1):e60. PubMed ID: 16435892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing effectiveness and access to HIV treatment in the developing world.
    Hill A; Wood E
    AIDS; 2007 Jan; 21(3):361-3. PubMed ID: 17255743
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools of the trade: a comparative analysis of approaches to priority setting in healthcare.
    Mitton C; Donaldson C
    Health Serv Manage Res; 2003 May; 16(2):96-105. PubMed ID: 12803949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationing HIV medications: what do patients and the public think about allocation policies?
    Green MJ; Fong S; Mauger DT; Ubel PA
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):56-62. PubMed ID: 11176269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.